SEP leads Series B round for Stentys
Scottish Equity Partners (SEP) has led an $18 million (£9.1 million) Series B funding round for cardio vascular device specialist Stentys. The investment in the Paris-headquartered company was also supported by existing investor Sofinnova Partners.
News